XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
REVENUES:      
Revenues $ 2,382,046 $ 2,259,126 $ 2,279,997
Cost of Goods Sold 1,557,264 1,519,253 1,582,236
Gross profit 824,782 739,873 697,761
OPERATING EXPENSES:      
Selling, general and administrative 638,762 606,693 608,345
Research and development 88,615 85,344 92,984
Restructuring, strategic transaction and integration expenses 59,840 41,258 71,421
Change in fair value of contingent earn-out (5,399) (16,247) (32,091)
Total operating expenses 781,818 717,048 740,659
Income from operations 42,964 22,825 (42,898)
Interest Expense, Net (95,753) (95,219) (66,375)
OTHER EXPENSE, NET (13,223) (5,905) (5,136)
Loss before income taxes (66,012) (78,299) (114,409)
(Provision) benefit for income taxes (51,676) 48,644 40,123
Net Loss $ (117,688) $ (29,655) $ (74,286)
Basic $ (4.83) $ (1.23) $ (3.11)
Diluted $ (4.83) $ (1.23) $ (3.11)
WEIGHTED AVERAGE NUMBER OF SHARES      
Basic (in shares) 24,388 24,091 23,868
Diluted (in shares) 24,388 24,091 23,868